Carisma Therapeutics Inc
NASDAQ:CARM

Watchlist Manager
Carisma Therapeutics Inc Logo
Carisma Therapeutics Inc
NASDAQ:CARM
Watchlist
Price: 0.0488 USD -0.41% Market Closed
Market Cap: 2m USD

Intrinsic Value

The intrinsic value of one CARM stock under the Base Case scenario is 0.7507 USD. Compared to the current market price of 0.0488 USD, Carisma Therapeutics Inc is Undervalued by 93%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CARM Intrinsic Value
0.7507 USD
Undervaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare CARM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CARM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carisma Therapeutics Inc

Current Assets 4.3m
Cash & Short-Term Investments 2m
Receivables 579k
Other Current Assets 1.7m
Non-Current Assets 717k
PP&E 717k
Current Liabilities 9m
Accounts Payable 4.8m
Accrued Liabilities 3.1m
Other Current Liabilities 1.1m
Non-Current Liabilities 42.1m
Other Non-Current Liabilities 42.1m
Efficiency

Free Cash Flow Analysis
Carisma Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Carisma Therapeutics Inc

Revenue
10.8m USD
Operating Expenses
-56.9m USD
Operating Income
-46.1m USD
Other Expenses
-3.3m USD
Net Income
-49.4m USD
Fundamental Scores

CARM Profitability Score
Profitability Due Diligence

Carisma Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Low 3Y Average Gross Margin
35/100
Profitability
Score

Carisma Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

CARM Solvency Score
Solvency Due Diligence

Carisma Therapeutics Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
24/100
Solvency
Score

Carisma Therapeutics Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CARM Price Targets Summary
Carisma Therapeutics Inc

There are no price targets for CARM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CARM Insider Trading
Buy and sell transactions by insiders